1[1]Schwartz GG, Olsson AG, Ezekowitz M, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial [J]. JAMA, 2001, 285(13):1711-1718.
2[2]Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis [J]. Circulation, 2002, 105(9):1135-1143.
3[3]Kinlay S, Selwyn AP. Effects of statins on inflammation in patients with acute and chronic coronary syndromes[J]. Am J Cardiol, 2003,91(4A):9B-13B.
4[4]Crisby M, Nordin-Fredriksson G, Shah PK, et al. Pravastatin treatment increases collagen content and decreases lipid content, inlammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization [J]. Circulation, 2001, 103(7):926-933.
5[5]Kinlay S, Timms T, Clark M, et al. Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia[J]. Am J Cardiol, 2002, 89(10):1205-1207.
6[6]Plenge JK, Hernandez TL, Weil KM, et al. Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction[J]. Circulation, 2002, 106(12): 1447-1452.
7[7]Albert MA, Danielson E, Rifai N, et al. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE):a randomized trial and cohort study[J]. JAMA, 2001,286(1):64-70.
8[8]Ardissino D, Merlini PA, Ariens R, et al. Tissue-factor antigen and activity in human coronary atherosclerotic plaques[J]. Lancet, 1997, 349(9054):769-771.
9[9]Baetta R, Camera M, Comparato C, et al. Fluvastatin reduces tissue factor expression and macrophage accumulation in carotid lesions of cholesterol-fed rabbits in the absence of lipid lowering[J]. Arterioscler Thromb Vasc Biol, 2002, 22(4):692-698.
10[10]Dujovne CA, Harris WS, Altman R, et al. Effect of atorvastatin on hemorheologic-hemostatin parameters and serum fibrinogen levels in hyperlipidemic patients [J]. Am J Cardiol, 2000,85(3):350-353.
7Luo Y,Jiang DY.Changes in serum imerleukin-6 and high-sensitivity C-reactive protein levels in patients with acute coronary syndeome and their responses to simvastatin[J].Heart Vessels,2004,19(6):257-262.
8Tonstad S,Sundfor T,Seljeflot I.Effect of lifestyle changes on atherogenie lipids and endothelial cell adhesion molecules in young adults with familial premature coronary heart disease[J].AMJ Cardiol,2005,95(10):1187-1191.
9Yusuf S,Hawken S,Upuu S,et al.Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries,a case-controlled study[J].Lancet,2005,366(9497):1640-1649.
10Yusuf S, HaWKens,Upaus,et al. Okesity and the risk of myocardial infarction in 27. 000 participants from 52 countries, a case controlled study[J]. I.ancet,2005,366(9497) :1640-1649.
